Filing metadata

Accession number
0001104659-22-023334
Form type
Form 5
Filer
POINT Biopharma Global Inc.
CIK
CIK 1811764
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Annual insider statement

Explore SEC Filings Hub